This study will assess an investigational treatment for patients diagnosed with all three major types of Epidermylosis Bullosa (EB).

The ESSENCE Study is a Phase 3 clinical trial of SD-101, an investigational topical cream being developed by Amicus, together with Scioderm, to treat skin blistering and lesions associated with Epidermylosis Bullosa.

Clinical Trial Overview

Clinical Trial Overview

Clinical Trial Overview

Clinical Trial Overview
The ESSENCE Study is a Phase 3 clinical trial of SD-101, an investigational topical cream being developed by Amicus, together with Scioderm, to treat skin blistering and lesions associated with EB. The painful symptoms and burden of daily wound care make EB a devastating illness with a significant unmet need among patients and families.